India diabetes care goes digital as RSSDI partners with Wellthy Therapeutics
21-Dec-16, The Hindu Business Line
Over the last 20 years, billions of dollars have been spent on pharma and med device research. Yet at the same time, the average blood sugar levels have remained the same, while the number of diabetics in India has tripled from ~20 million in 1995 to ~70m in 2015. India is home to 17% of the world’s diabetics.
%20The%20Hindu%20Business%20Line.jpg "India diabetes care goes digital as RSSDI partners with Wellthy Therapeutics (c) The Hindu Business Line")
Image: The Hindu Business Line
Lack of infrastructure, overworked doctors, high cost of delivering care and an already large annual burden of cost on diabetic patients are challenges that must be overcome. Artificial intelligence makes this possible.
In a multi-year partnership, Wellthy Therapeutics and RSSDI will work together to develop and deploy care protocols and guidelines for lifestyle and behavioural modifications for diabetes patients in India, and to enable real time decision support for doctors. Wellthy Therapeutics will offer the diabetes prescription app for all doctors who are members of RSSDI.